<DOC>
	<DOC>NCT02230761</DOC>
	<brief_summary>This study will test whether XAF5 (XOPH5) ointment, applied once daily to the lower eyelids for 10 weeks, reduces the prominence of lower eyelid fat in adults with moderate to severe steatoblepharon (excess eyelid fat).</brief_summary>
	<brief_title>Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon)</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria (abbreviated): Moderate to severe lower eyelid steatoblepharon (LESS score of 24 bilaterally) Men and women 4070 years old Healthy facial skin Must understand and provide informed consent Exclusion Criteria (abbreviated): Best corrected visual acuity worse than 20/40 in either eye Regular use of ophthalmic medication in either eye Planned use of contact lenses during the study Any history of lower eyelid surgery</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>steatoblepharon</keyword>
	<keyword>blepharoptosis</keyword>
	<keyword>dermatochalasis</keyword>
	<keyword>blepharoplasty</keyword>
	<keyword>periorbital</keyword>
	<keyword>orbital</keyword>
	<keyword>eyelid</keyword>
	<keyword>eyebags</keyword>
	<keyword>eye bags</keyword>
</DOC>